Topics

Endocrinology

Notifying a doctor of a first hypoglycaemic episode is associated with a lower rate of recurrence among inpatients with diabetes

To the Editor: Hypoglycaemia is a common problem in inpatients with diabetes and is associated with morbidity and mortality.,2 We conducted a retrospective single-centre cohort study to evaluate the management (notifying a doctor and taking appropriate preventive actions, defined as altering the hypoglycaemic agent that led to the event or commencing dextrose in appropriate cases by the doctor) of the first hypoglycaemic episode and its ...

Dilantha T De Alwis · Suresh Varadarajan · Kwang Lim

Endocrinology Letters 2 September 2013 Free

Consistently high incidence of diabetic ketoacidosis in children with newly diagnosed type 1 diabetes

To the Editor: Data from the tertiary paediatric hospitals in Brisbane (Royal Children’s and Mater Children’s Hospitals) support Claessen and colleagues’ letter.1 A total of 1091 children aged < 18 years were initially admitted from 1 January 2001 to 31 December 2011 with a new diagnosis of type 1 diabetes (T1D) (Box). Diabetic ketoacidosis (DKA) was defined as venous pH < 7.3 or serum bicarbonate level < 15 mmol/L in association with hyperglycaemia and ketoacidosis. Severity was defined ...

Carol M Willis · Jennifer A Batch · Mark Harris

Endocrinology Clinical focus 2 September 2013 Free

The rationale for combining GLP-1 receptor agonists with basal insulin

The use of glucagon-like peptide-1 receptor agonists combined with basal insulins is emerging as an option for treating patients with type 2 diabetes mellitus. However, cost, gastrointestinal side effects and long-term safety should be taken into account.

Neale D Cohen MB BS, FRACP · Ralph Audehm MB BS, DipRACOG · Elaine Pretorius MB ChB, FCP(SA), FRACP · Joey Kaye MB BS, FRACP, PhD · Leon H Chapman MB BS, FRACP · Stephen Colagiuri MB BS, FRACP

12 11856
Endocrinology In this issue 19 August 2013 Free

A three-word slogan: stop the bloat

Like typhoid and cholera two centuries ago, there is real opportunity in Australia, with appropriate public health strategies, to cut the overall burden of diabetes and the toll that it exacts.

Astika Kappagoda

Endocrinology Letters 17 June 2013 Free

Gestational diabetes needs to be managed

To the Editor: McIntyre and Oats promote the International Association of the Diabetes and Pregnancy Study Groups (IADPSG) criteria for gestational diabetes mellitus (GDM) as being well reasoned.1 Derived from observational data and mathematical modelling in an attempt to provide a worldwide definition and to improve outcomes, these criteria will significantly increase the number of women diagnosed with GDM2 in health care systems that have ...

Adrian V G Taylor

10195
Endocrinology Letters 17 June 2013 Free

Gestational diabetes needs to be managed

To the Editor: McIntyre and Oats1 suggest that Australian medical practitioners should adopt the new International Association of the Diabetes and Pregnancy Study Groups (IADPSG) diagnostic criteria for the management of gestational diabetes mellitus (GDM),2 mainly because of the findings of the Hyperglycemia and Adverse Pregnancy Outcome (HAPO) study.3 If adopted, a significant number of women will be diagnosed with GDM if their only blood ...

Michael C d’Emden · Narelle D Fagermo · Amanda J Love · Karin M C Lust

13 10433
Endocrinology Letters 17 June 2013 Free

Gestational diabetes needs to be managed

In reply: Taylor welcomes a strong evidence base for clinical practice, which is echoed by d’Emden and colleagues. However, their strong support for the current Australian diagnostic criteria for gestational diabetes mellitus (GDM) is surprising, given that these criteria are the product of an “Ad Hoc Working Party” report.1 This guideline, published in 1991, clearly acknowledged a lack of strong evidence and advocated criteria that ...

H David McIntyre · Jeremy J N Oats

13 10421
Endocrinology Letters 17 June 2013 Free

Controversy grows over redefinition of gestational diabetes

To the Editor: Moynihan has recently suggested that gestational diabetes mellitus (GDM) is a “non-entity”1 and cited controversy regarding new diagnostic criteria, while McIntyre and Oats have defended the practice of screening for GDM.2 Robust data associate hyperglycaemia with adverse pregnancy outcomes;3 and randomised controlled trial data show a beneficial effect of screening and treatment on perinatal outcomes.4 However, it is short-sighted to consider only the ...

Mark McLean · Len D Moaven · Naswrin Moin · Jennifer A Bradford

12 11326

Improved iodine status in Tasmanian schoolchildren after fortification of bread: a recipe for national success

A cross-sectional survey of Tasmanian students aged 8–13 years finds that mandatory iodine fortification of bread appears to have achieved the goal of significantly improving iodine status in this population. However, further research is needed to assess the effects of mandatory fortification in pregnant and breastfeeding women.

Kate M DePaoli BSc(Hons)(Diet) · Judy A Seal BAppSci, GradDipDiet, MPH · John R Burgess FRACP, MD, PhD · Roscoe Taylor MB BS, FAFPHM, GradDipEpid

Endocrinology Perspectives 21 January 2013 Free

Managing diabetes and preventing complications: what makes the difference?

Greater emphasis is needed on behavioural and psychosocial aspects in research and clinical practiceWednesday 14 November marks World Diabetes Day, the birthday of Sir Frederick Banting, whose research led to the discovery of insulin in 1922. In the 90 years since, there have been other significant landmarks. The Diabetes Control and Complications Trial (DCCT)1 and United Kingdom Prospective Diabetes Study (UKPDS)2 showed that the devastating complications of ...

Jane Speight PhD, CPsychol, AFBPsS

Endocrinology Research 21 January 2013 Free

Growth and pubertal development of adolescent boys on stimulant medication for attention deficit hyperactivity disorder

In a cohort of 65 boys aged 12–16 years at recruitment, treatment for more than 3 years with stimulant medication was associated with a slower rate of physical development during puberty, compared with boys not taking stimulants.

Alison S Poulton MA, MB BChir, MD · Elaine Melzer RN, RM, OAM · Paul R Tait MB BS, FRACP · Sarah P Garnett BSc, MNutrDiet, PhD · Chris T Cowell MB BS, FRACP · Louise A Baur MB BS, PhD, FRACP · Simon Clarke MB BS, FRACP, FCP

Endocrinology Letters 19 November 2012 Free

Vitamin D and health in adults in Australia and New Zealand: a position statement

To the Editor: Our scepticism about the value of many of the burgeoning number of clinical guidelines is reinforced by the position statement on vitamin D and health for adults.1 It was surprising not to find an explicit statement that there is Level I evidence that vitamin D monotherapy does not prevent falls2 or fractures3 or reduce mortality.4 Instead, Nowson and colleagues conclude that “there ...

Mark J Bolland · Andrew Grey · Tim Cundy

Endocrinology Letters 19 November 2012 Free

Vitamin D and health in adults in Australia and New Zealand: a position statement

In reply: Our position statement summarised findings from the most relevant peer-reviewed literature.1 We clearly acknowledged that there are inconsistencies in the literature, as is often the case in many fields of medicine. Most Level I evidence indicates that vitamin D (combined with adequate calcium) reduces falls and fractures in older people. Mortality is also reduced.2 The combination of vitamin D supplementation with adequate calcium does ...

On behalf of the Working Group of the Australian and New Zealand Bone and Mineral Society, Endocrine Society of Australia and Osteoporosis Australia

Endocrinology Letters 5 November 2012 Free

Adverse effects of adult topical androgen use on children

We read with interest the report by Handelsman describing an increase in Australian testosterone prescriptions, including a particular increase in prescribing of topical testosterone gel. The topically applied formulation of testosterone has a unique adverse-effect profile because of inadvertent exposure to it via direct skin contact. We report progressive virilisation in a 2-year-old girl who presented in 2011 with an 18-month history of body ...

Jacqueline K Hewitt · Margaret R Zacharin

Endocrinology Letters 17 September 2012 Free

Pharmacoepidemiology of testosterone prescribing in Australia, 1992–2010

To the Editor: Could Handelsman comment on whether he considered opioid-associated hypoandrogenism when describing the increasing prescribing of testosterone?1 Opioid-induced androgen deficiency has become more recognised, and is one of the most common causes of testosterone deficiency among men in many communities.2,3 It may be that the increase in opioid prescribing4 has complemented the promotion of testosterone therapy. Stephen P Fitzgerald General Physician and Endocrinologist

Stephen P Fitzgerald

Endocrinology Letters 17 September 2012 Free

Pharmacoepidemiology of testosterone prescribing in Australia, 1992–2010

To the Editor: The recent article by Handelsman describes the pattern of testosterone prescribing in Australia from January 1992 to December 2010.1 The author concludes that the progressive increase in Pharmaceutical Benefits Scheme (PBS)-subsidised testosterone prescribing is likely to be due to promotion-driven prescribing for speculative, non-approved indications.1 The article does not make any reference to the prescribing of testosterone for opioid-induced androgen deficiency. The use of ...

Peter M Herriot

Subscribe to MJA email alerts

No spam, you can unsubscribe anytime you want.

By providing your information, you agree to our Terms of Use and our Privacy Policy.

Thanks for Subscribing! Tell us more

Your email updates will use your name.

Good one! Your updates are coming

Thank you for subscribing to the MJA email alerts. Receive the latest content in your inbox.